Alexandra Hospital is an acute general hospital in Redditch, Worcestershire, England. It is managed by the Worcestershire Acute Hospitals NHS Trust.

During the past decade, Alexandra Healthcare NHS conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 2 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Alexandra Healthcare NHS" #1 sponsor was "Institute of Cancer Research, United Kingdom" with 4 trials, followed by "University College, London" with 3 trials sponsored, "Wales Cancer Trials Unit" with 2 trials sponsored, "Boehringer Ingelheim" with 1 trials sponsored and "Cancer Research UK" with 1 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Alexandra Healthcare NHS" #1 collaborator was "Cancer Research UK" with 3 trials as a collaborator, "Borstkanker Onderzoek Groep" with 1 trials as a collaborator, "Breast International Group" with 1 trials as a collaborator, "Cancer Trials Ireland" with 1 trials as a collaborator and "Celgene" with 1 trials as a collaborator. Other collaborators include 8 different institutions and companies that were collaborators in the rest 18 trials.

According to Clinical.Site data, the most researched conditions in "Alexandra Healthcare NHS" are "Breast Cancer" (5 trials), "Prostate Cancer" (4 trials), "Metastatic Cancer" (3 trials), "Lung Cancer" (2 trials) and "Adenocarcinoma" (1 trials). Many other conditions were trialed in "Alexandra Healthcare NHS" in a lesser frequency.

Most popular intervention types in "Alexandra Healthcare NHS" are "Drug" (14 trials), "Procedure" (6 trials), "Radiation" (4 trials), "Biological" (3 trials) and "Other" (3 trials). Other intervention types were less common.

The name of intervention was led by "adjuvant therapy" (3 trials), "capecitabine" (3 trials), "radiation therapy" (3 trials), "cyclophosphamide" (2 trials) and "epirubicin hydrochloride" (2 trials). Other intervention names were less common.

The vast majority of trials in "Alexandra Healthcare NHS" are 13 trials for "All" genders, 4 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Alexandra Healthcare NHS". undefined are not yet recruiting, 2 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Alexandra Healthcare NHS, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Alexandra Healthcare NHS, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".